financetom
Business
financetom
/
Business
/
Trive Capital-backed Karman, shareholders raise $506 million in upsized IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trive Capital-backed Karman, shareholders raise $506 million in upsized IPO
Feb 13, 2025 3:27 AM

(Reuters) - Karman Holdings ( KRMN ) and some of its existing shareholders raised $506 million in an upsized New York initial public offering, fetching a valuation of nearly $3 billion for the defense and space systems maker.

They sold 23 million shares on Wednesday at $22 apiece, above the marketed range of $18 to $20, the Huntington Beach, California-based company said.

Karman ( KRMN ) sold roughly 8.4 million shares, and the others, about 14.6 million. They had earlier aimed for a sale of roughly 21 million shares.

Shares of the company, backed by private equity firm Trive Capital, will start trading on the New York Stock Exchange on February 13, under ticker symbol "KRMN".

Trive Capital will continue to own a majority of the voting power at Karman ( KRMN ) after the IPO.

(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Shinjini Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
Aug 25, 2025
MannKind Corporation on Monday agreed to acquire scPharmaceuticals Inc. for a deal value of up to approximately $360 million, or $5.35 per share. The deal marks MannKind’s strategic expansion into cardiorenal medicine, establishing its cardiometabolic business alongside its orphan lung division. It is also made possible on the heels of MannKind’s $500 million strategic financing agreement with Blackstone. ScPharmaceuticals ( SCPH...
Trump says China has to give US magnets or face 200% tariff
Trump says China has to give US magnets or face 200% tariff
Aug 25, 2025
(Reuters) -President Donald Trump told reporters on Monday that China has to give the United States magnets or we have to charge them 200% tariff or something amid a trade dispute between the two nations. China is increasingly sensitive about rare earths and its control over supply, adding several rare earth items and magnets to its export restriction list in...
AbbVie to Buy Experimental Depression Drug From Gilgamesh For up to $1.2 Billion
AbbVie to Buy Experimental Depression Drug From Gilgamesh For up to $1.2 Billion
Aug 25, 2025
01:31 PM EDT, 08/25/2025 (MT Newswires) -- AbbVie ( ABBV ) will acquire Gilgamesh Pharmaceuticals' investigational depression drug for up to $1.2 billion, expanding its psychiatry pipeline, the companies said Monday. The acquisition price for Gilgamesh' lead asset, bretisilocin, includes an upfront payment and milestones-based consideration. The transaction is subject to closing conditions. A phase 2a study of bretisilocin targeting...
FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles
FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles
Aug 25, 2025
The U.S. Food and Drug Administration (FDA) has identified repeated quality control failures, including foreign particle contamination, inadequate investigations, and insufficient corrective actions at the Novo Nordisk A/S operated facility in Bloomington, Indiana. In 2024, Novo Nordisk ( NVO ) acquired three fill-finish sites from Novo Holdings A/S for $11 billion. The acquisition was part of a larger deal where...
Copyright 2023-2026 - www.financetom.com All Rights Reserved